Relugolix Completed Phase 1 Trials for Hormone Treatment-naïve Participants With Prostate Cancer / Androgen Deprivation Treatment-naïve Nonmetastatic Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02141659A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer